Search results
Results From The WOW.Com Content Network
Precision diagnostics is a branch of precision medicine that involves managing a patient's healthcare model and diagnosing specific diseases based on omics data analytics. [1] The U.S. announced federal funding for precision medicine research efforts in 2015 with the Precision Medicine Initiative. A year later, the Human Personal Omics ...
Alere Inc. was a global manufacturer of rapid point-of-care diagnostic tests.The company was founded in 1991 and was headquartered in Waltham, Massachusetts. [2] [3] As of January 2017, the company had a market capitalization of $3.47 billion with an enterprise value of $5.9 billion. [1]
Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics. [12] [14] Precision medicine and personalized medicine (also individualized medicine) are analogous, applying a person's genetic profile to guide clinical decisions about the prevention, diagnosis, and treatment of a disease. [15]
AIDA64 is a system information, diagnostics, ... FPU Julia — tests the performance of the processor's floating-point units in 32-bit precision calculations.
An analyte is a substance, chemical or biological, that is being analyzed using a certain instrument. While point-of-care testing is the quantification of one analyte from one in vitro (e.g., blood, plasma or urine) sample, multiplexed point-of-care testing is the simultaneous on-site quantification of various analytes from a single sample. [2]
Therefore, multiplexed point-of-care testing (xPOCT) has become more important for medical diagnostics in the last decade. [11] Many point-of-care test systems are realized as easy-to-use membrane-based test strips, often enclosed by a plastic test cassette. [2]
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Clearblue has also launched ovulation and fertility home diagnostic products to help women identify their fertile days and to maximize their chances of conception. [10] In 1989, Clearblue released the first one-step home ovulation test, enabling women to measure their surge in Luteinising Hormone (LH) to determine their most fertile days.